Analysis of clinical correlation between RAB26 expression in prostate cancer (IMAGE)

Compuscript Ltd

Analysis of clinical correlation between RAB26 expression in prostate cancer

Caption

(A) Expression density map of single-cell sequencing cell typing in prostate cancer. (B) UMAP diagram of RAB26 in prostate cancer cells. (C) Expression of RAB26 in different cell types. (D) Expression of RAB26 in different tumors. (E) RAB26 and progression-free survival. (F) RAB26 and disease-free survival. (G) The relationship between RAB26 and the T stage of prostate cancer. (H) The relationship between RAB26 and lymph node metastasis in prostate cancer. (I) The relationship between RAB26 and different Gleason scores. (J) Differential expression of RAB26 between normal prostate tissue and prostate cancer tissue. (K) Western blotting detected RAB26 in the tumor and para-carcinoma tissues of patients with prostate cancer. (L) The immunohistochemical staining of RAB26 in patients with prostate cancer. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001.

Credit

Hexi Wang, Simin Liang, Xiaoyi Du, Guozhi Zhao, Yuanyuan Bai, Junwu Li, Haoyu Xu, Senlin Peng, Ye Yuan, Wei Tang

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.